NSN 6505-01-503-6755
Part Details | EPTIFIBATIDE INJECT
6505-01-503-6755
Alternate Parts: 021714, 02-1714, 6505NCM021033, NDC00085117701, NDC00085-1177-01, NDC00085117701, NDC00085-1177-01, INTEGRILIN, 6505-01-503-6755, 01-503-6755, 6505015036755, 015036755
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-503-6755
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| 02-1714 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
| 6505NCM021033 | 64616 | DEFENSE MEDICAL STANDARDIZATIONBOARD |
| NDC00085-1177-01 | 6B2S4 | MERCK SHARP & DOHME CORP. |
| NDC00085-1177-01 | 53300 | SCHERING CORPAN AFFIL OF SCHERING-PLOUGH CORP |
| INTEGRILIN | 53300 | SCHERING CORPAN AFFIL OF SCHERING-PLOUGH CORP |
Technical Data | NSN 6505-01-503-6755
| Characteristic | Specifications |
|---|---|
| SPECIAL FEATURES | 10 ML VIAL CONTAINS 2MG/ML EPTIFIBATIDE;SOLUTION IS CLEAR, STERILE, COLORLESS, NON-PYROGENIC; FOR INTRAVENOUS (IV) USE; VIALS SHOULD BE STORED REFRIGERATED 2-8 DEG.C, OR AT ROOM TEMP. FOR UP TO 2 MONTHS ONLY; PROTECT FROM DIRECT LIGHT; DISCARD ANY UNUSED PORTION; TO HELP PATIENTS WITH SEVERE CARDIOVASCULAR DISEASES |
| AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER | 920000 |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | EPTIFIBATIDE INJECTION 10ML VIAL 2MG/ML EPTIFIBATIDE SOLUTION |
